NCT00659087

Brief Summary

Hospital stays after total joint replacement surgery have been getting shorter over the past 10 years. This is mostly due to new ways to manage pain and early rehabilitation. To be able to go home safely soon after surgery, patients need to:

  • 1\) have adequate pain control
  • 2\) be able to move through activities of daily living on their own (using aids) Femoral nerve block, in combination with pain medications, is one of the new treatment strategies that are currently being used at other hospitals in Canada, the United States and the United Kingdom. Nerve blocks involve a needle filled with local anesthetic into the nerve that allows the feeling of pain around the knee. With good pain management, patients will be able to more quickly bend their knee and regain the ability to walk with aids and move from sitting and lying positions to standing and walking. Once they can do these activities with adequate pain control, they can be discharged from hospital to continue recovery at home. The purpose of this study is to examine a new way of managing postoperative pain and encourage early knee flexion and mobility, while maintaining pain control for patients after total knee replacement. We believe that patients who receive the nerve block in addition to the regular pain medication will have more knee flexion at discharge and experience less pain than patients who only receive usual pain medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Apr 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 16, 2008

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

August 3, 2016

Status Verified

August 1, 2016

Enrollment Period

1.5 years

First QC Date

April 10, 2008

Last Update Submit

August 2, 2016

Conditions

Keywords

Total KneeRange of MotionPain

Outcome Measures

Primary Outcomes (1)

  • knee flexion

    at hospital discharge or day 4 postoperatively, whichever is earlier

Secondary Outcomes (4)

  • pain

    daily in hospital, 2 weeks, 6 weeks, 12 weeks

  • length of hospital stay

    during hospitalization

  • nausea/vomiting

    during hospitalization

  • participation in rehabilitation

    day of surgery

Study Arms (2)

Femoral Block

EXPERIMENTAL

Those receiving femoral block in addition to usual pain management

Procedure: Femoral Block

Usual Care

ACTIVE COMPARATOR

Those receiving only usual pain management without a femoral block

Other: Usual Care

Interventions

Femoral BlockPROCEDURE

Those receiving femoral block postoperatively

Femoral Block

Those receiving only usual pain management postoperatively

Usual Care

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing primary total knee arthroplasty
  • English-speaking
  • Preoperative knee ROM \> 90 degrees
  • Body Mass Index \< 40

You may not qualify if:

  • Regular preoperative opioid use
  • Hepatic insufficiency
  • Any contra-indications to receiving a femoral block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospitals

Edmonton, Alberta, T6G 2B7, Canada

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric and Adult Anesthesiologist, Associate Professor/Director of Clinical Research, Stollery Children's Hospital/University of Alberta Hospital

Study Record Dates

First Submitted

April 10, 2008

First Posted

April 16, 2008

Study Start

April 1, 2008

Primary Completion

October 1, 2009

Study Completion

December 1, 2009

Last Updated

August 3, 2016

Record last verified: 2016-08

Locations